These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 38169921)
1. Lipid metabolism-derived FAAH is a sensitive marker for the prognosis and immunotherapy of osteosarcoma patients. Shi Y; Wu S; Zhang X; Cao Y; Zhang L Heliyon; 2024 Jan; 10(1):e23499. PubMed ID: 38169921 [TBL] [Abstract][Full Text] [Related]
2. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma. Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X Front Oncol; 2023; 13():1182434. PubMed ID: 37346073 [TBL] [Abstract][Full Text] [Related]
3. Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties. Patricelli MP; Lovato MA; Cravatt BF Biochemistry; 1999 Aug; 38(31):9804-12. PubMed ID: 10433686 [TBL] [Abstract][Full Text] [Related]
4. A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma. Xu K; Xia P; Liu P; Zhang X Sci Rep; 2022 Dec; 12(1):20781. PubMed ID: 36456877 [TBL] [Abstract][Full Text] [Related]
5. Expression of Lipid-Metabolism Genes Is Correlated With Immune Microenvironment and Predicts Prognosis in Osteosarcoma. Qian H; Lei T; Hu Y; Lei P Front Cell Dev Biol; 2021; 9():673827. PubMed ID: 33937273 [TBL] [Abstract][Full Text] [Related]
6. Tumour epithelial expression levels of endocannabinoid markers modulate the value of endoglin-positive vascular density as a prognostic marker in prostate cancer. Fowler CJ; Josefsson A; Thors L; Chung SC; Hammarsten P; Wikström P; Bergh A Biochim Biophys Acta; 2013 Oct; 1831(10):1579-87. PubMed ID: 23262399 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA miR-1275 coordinately regulates AEA/LPA signals via targeting FAAH in lipid metabolism reprogramming of gastric cancer. Yang Q; Kong S; Yu J; Xu Y; Tao M; Ma S; Tang C; Shen X; Tang Z; Ju S Cell Death Dis; 2023 Jan; 14(1):62. PubMed ID: 36702852 [TBL] [Abstract][Full Text] [Related]
8. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma. Yang H; Zhao L; Zhang Y; Li FF Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887 [TBL] [Abstract][Full Text] [Related]
9. A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes. Tang H; Liu S; Luo X; Sun Y; Li X; Luo K; Liao S; Li F; Liang J; Zhan X; Wei Q; Liu Y; He M Front Immunol; 2023; 14():1150588. PubMed ID: 37090691 [TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis. Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H Front Immunol; 2022; 13():997765. PubMed ID: 36275664 [TBL] [Abstract][Full Text] [Related]
11. The Prognostic Model Established by the Differential Expression Genes Based on CD8 Chen Y; Yan W; Wang H; Ou Z; Chen H; Huang Z; Yang J; Liu B; Ou F; Zhang H Mediators Inflamm; 2023; 2023():6563609. PubMed ID: 36816742 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of apoptosis-related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients. Hong J; Li Q; Wang X; Li J; Ding W; Hu H; He L J Clin Lab Anal; 2022 Jul; 36(7):e24501. PubMed ID: 35576501 [TBL] [Abstract][Full Text] [Related]
13. Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerization. Patricelli MP; Lashuel HA; Giang DK; Kelly JW; Cravatt BF Biochemistry; 1998 Oct; 37(43):15177-87. PubMed ID: 9790682 [TBL] [Abstract][Full Text] [Related]
14. Keys to Lipid Selection in Fatty Acid Amide Hydrolase Catalysis: Structural Flexibility, Gating Residues and Multiple Binding Pockets. Palermo G; Bauer I; Campomanes P; Cavalli A; Armirotti A; Girotto S; Rothlisberger U; De Vivo M PLoS Comput Biol; 2015 Jun; 11(6):e1004231. PubMed ID: 26111155 [TBL] [Abstract][Full Text] [Related]
15. By using machine learning and Xia G; Wu S; Luo K; Cui X Front Oncol; 2023; 13():1180191. PubMed ID: 37091161 [TBL] [Abstract][Full Text] [Related]
16. Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancer. Liu L; Mo M; Chen X; Chao D; Zhang Y; Chen X; Wang Y; Zhang N; He N; Yuan X; Chen H; Yang J J Exp Clin Cancer Res; 2023 Apr; 42(1):85. PubMed ID: 37055842 [TBL] [Abstract][Full Text] [Related]
17. CYP19A1 promotes gastric cancer as part of a lipid metabolism-related gene signature related to the response of immunotherapy and prognosis. Zhou X; Meng F; Xiao L; Shen H BMC Med Genomics; 2023 Oct; 16(1):228. PubMed ID: 37784135 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel lipid metabolism-related gene signature within the tumour immune microenvironment for breast cancer. Chang X; Xing P Lipids Health Dis; 2022 May; 21(1):43. PubMed ID: 35562758 [TBL] [Abstract][Full Text] [Related]
19. Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity. Ahn K; Johnson DS; Fitzgerald LR; Liimatta M; Arendse A; Stevenson T; Lund ET; Nugent RA; Nomanbhoy TK; Alexander JP; Cravatt BF Biochemistry; 2007 Nov; 46(45):13019-30. PubMed ID: 17949010 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance and immune landscape of a novel ferroptosis-related prognosis signature in osteosarcoma. Yang L; Liu J; Liu S BMC Cancer; 2023 Mar; 23(1):229. PubMed ID: 36899330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]